(VIANEWS) – BancorpSouth (BXS), Alexandria Real Estate Equities (ARE), TJX Companies (TJX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BancorpSouth (BXS)

57.4% sales growth and 10.33% return on equity

BancorpSouth Bank provides commercial banking and financial services to individuals and small-to-medium size businesses.

BancorpSouth’s sales growth this year is anticipated to be 16.8% and 47.4% for next year.

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 1.03B for the twelve trailing months.

Volume

Today’s last reported volume for BancorpSouth is 19263400 which is 1096.25% above its average volume of 1610320.

BancorpSouth’s sales growth for the next quarter is 57.4%. The company’s growth estimates for the present quarter and the next is a negative 7.2% and negative -155.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.33%.

Volatility

BancorpSouth’s last day, last week, and last month’s current intraday variation average was 0.43%, 0.67%, and 1.72%, respectively.

BancorpSouth’s highest amplitude of average volatility was 1.13% (day), 1.82% (last week), and 2.93% (last month), respectively.

BancorpSouth’s Stock Yearly Top and Bottom Value

BancorpSouth’s stock is valued at $28.76 at 19:22 EST, way below its 52-week high of $35.59 and way above its 52-week low of $24.87.

BancorpSouth’s Moving Average

BancorpSouth’s value is under its 50-day moving average of $30.17 and under its 200-day moving average of $29.14.

2. Alexandria Real Estate Equities (ARE)

31.8% sales growth and 7.21% return on equity

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500 urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $27.7 billion as of June 30, 2020, and an asset base in North America of 43.0 million square feet ("SF").

Alexandria Real Estate Equities’s sales growth this year is anticipated to be 6.6% and 12.6% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 2.02B for the twelve trailing months.

Volume

Today’s last reported volume for Alexandria Real Estate Equities is 1794660 which is 163.7% above its average volume of 680555.

Alexandria Real Estate Equities’s sales growth is a negative 0% for the present quarter and 31.8% for the next. The company’s growth estimates for the current quarter and the next is a negative 1.6% and negative -82.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.

Volatility

Alexandria Real Estate Equities’s last day, last week, and last month’s current intraday variation average was 1.54%, 0.49%, and 0.63%, respectively.

Alexandria Real Estate Equities’s highest amplitude of average volatility was 2.41% (day), 1.01% (last week), and 1.52% (last month), respectively.

Alexandria Real Estate Equities’s Stock Yearly Top and Bottom Value

Alexandria Real Estate Equities’s stock is valued at $209.84 at 19:22 EST, below its 52-week high of $213.25 and way above its 52-week low of $154.37.

Alexandria Real Estate Equities’s Moving Average

Alexandria Real Estate Equities’s value is higher than its 50-day moving average of $204.10 and way above its 200-day moving average of $190.71.

3. TJX Companies (TJX)

27.2% sales growth and 27.8% return on equity

The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer.

TJX Companies’s sales growth this year is anticipated to be 50.3% and 6.5% for next year.

Year-on-year quarterly revenue growth grew by 128.8%, now sitting on 37.81B for the twelve trailing months.

Volume

Today’s last reported volume for TJX Companies is 3410300 which is 48.19% below its average volume of 6583540.

TJX Companies’s sales growth is a negative 0% for the ongoing quarter and 27.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 14.1% and 82%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.8%.

Volatility

TJX Companies’s last day, last week, and last month’s current intraday variation average was 2.10%, 1.99%, and 0.92%, respectively.

TJX Companies’s highest amplitude of average volatility was 2.98% (day), 2.84% (last week), and 1.76% (last month), respectively.

TJX Companies’s Stock Yearly Top and Bottom Value

TJX Companies’s stock is valued at $75.47 at 19:22 EST, below its 52-week high of $76.94 and way above its 52-week low of $61.15.

TJX Companies’s Moving Average

TJX Companies’s value is way higher than its 50-day moving average of $68.15 and way above its 200-day moving average of $68.50.

4. Catalyst Pharmaceuticals (CPRX)

15.6% sales growth and 49.72% return on equity

Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.

Catalyst Pharmaceuticals’s sales growth this year is anticipated to be 14.1% and 20.3% for next year.

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 728141 which is 24.45% below its average volume of 963831.

Catalyst Pharmaceuticals’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the ongoing quarter and the next is a negative 75.6% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.72%.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 1.38%, 2.41%, and 2.07%, respectively.

Catalyst Pharmaceuticals’s highest amplitude of average volatility was 4.31% (day), 4.39% (last week), and 4.25% (last month), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $6.60 at 19:22 EST, way under its 52-week high of $7.58 and way above its 52-week low of $3.27.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $6.53 and way higher than its 200-day moving average of $5.51.

5. Colfax Corporation (CFX)

11.9% sales growth and 3.18% return on equity

Colfax Corporation operates as a diversified technology company worldwide.

Colfax Corporation’s sales growth this year is anticipated to be 25.2% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 3.66B for the twelve trailing months.

Volume

Today’s last reported volume for Colfax Corporation is 385351 which is 65.81% below its average volume of 1127250.

Colfax Corporation’s sales growth for the next quarter is 11.9%. The company’s growth estimates for the ongoing quarter and the next is 13.7% and 27.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.18%.

Volatility

Colfax Corporation’s last day, last week, and last month’s current intraday variation average was 0.41%, 0.76%, and 1.56%, respectively.

Colfax Corporation’s highest amplitude of average volatility was 1.30% (day), 1.69% (last week), and 2.78% (last month), respectively.

Colfax Corporation’s Stock Yearly Top and Bottom Value

Colfax Corporation’s stock is valued at $46.13 at 19:22 EST, way below its 52-week high of $54.67 and way above its 52-week low of $36.59.

Colfax Corporation’s Moving Average

Colfax Corporation’s value is below its 50-day moving average of $48.69 and under its 200-day moving average of $46.51.

6. Columbia Banking System (COLB)

10.4% sales growth and 9.44% return on equity

Columbia Banking System, Inc. operates as the bank holding company for Columbia State Bank that provides a range of banking services to small and medium-sized businesses, professionals, and individuals in Washington, Oregon, and Idaho.

Columbia Banking System’s sales growth this year is anticipated to be 6.7% and 107.2% for next year.

Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 617.52M for the twelve trailing months.

Volume

Today’s last reported volume for Columbia Banking System is 693372 which is 15.25% below its average volume of 818147.

Columbia Banking System’s sales growth for the next quarter is 10.4%. The company’s growth estimates for the present quarter and the next is a negative 28% and negative -13.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.44%.

Volatility

Columbia Banking System’s last day, last week, and last month’s current intraday variation average was 0.15%, 0.91%, and 1.10%, respectively.

Columbia Banking System’s highest amplitude of average volatility was 1.54% (day), 2.03% (last week), and 2.55% (last month), respectively.

Columbia Banking System’s Stock Yearly Top and Bottom Value

Columbia Banking System’s stock is valued at $33.71 at 19:22 EST, way below its 52-week high of $50.68 and way higher than its 52-week low of $30.09.

Columbia Banking System’s Moving Average

Columbia Banking System’s worth is below its 50-day moving average of $33.89 and way below its 200-day moving average of $37.75.

7. CrossFirst Bankshares (CFB)

5.6% sales growth and 8.93% return on equity

CrossFirst Bankshares’s sales growth this year is expected to be 8.6% and 2.4% for next year.

Year-on-year quarterly revenue growth grew by 55.9%, now sitting on 164.87M for the twelve trailing months.

Volume

Today’s last reported volume for CrossFirst Bankshares is 60584 which is 39.77% below its average volume of 100601.

CrossFirst Bankshares’s sales growth for the next quarter is 5.6%. The company’s growth estimates for the current quarter and the next is 100% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.93%.

Volatility

CrossFirst Bankshares’s last day, last week, and last month’s current intraday variation average was 1.39%, 1.36%, and 1.44%, respectively.

CrossFirst Bankshares’s highest amplitude of average volatility was 4.03% (day), 3.30% (last week), and 3.16% (last month), respectively.

CrossFirst Bankshares’s Stock Yearly Top and Bottom Value

CrossFirst Bankshares’s stock is valued at $15.38 at 19:22 EST, below its 52-week high of $15.67 and way above its 52-week low of $10.58.

CrossFirst Bankshares’s Moving Average

CrossFirst Bankshares’s value is higher than its 50-day moving average of $14.64 and above its 200-day moving average of $14.05.

LEAVE A REPLY

Please enter your comment!
Please enter your name here